3rd Edition on International
Neurology Conference 2025 in Orlando, USA
Abstract Submission :April 30, 2025
Early Bird Registration : May-15, 2025
EVENT DATE
November, 15-16, 2025
Neurology Conferences 2025 USA
The conference will explore key topics such as neuroplasticity, the impact of trauma on brain function, depression, anxiety, and emerging insights into the mind-brain axis. Building on the legacy of our past globally acclaimed Neuroscience Conferences, this edition promises an engaging, interdisciplinary platform for knowledge sharing and collaborative advancement.
We extend our warm invitation to neurologists, psychologists, clinical therapists, neurosurgeons, researchers, and mental health professionals to join us in shaping the future of patient care and neuroscience innovation. Don’t miss this opportunity to contribute to meaningful dialogue, present your research, and expand your professional network.
- Dates: November 15-16 , 2025
- Location: Florida , USA
- Neurology Residents and Fellows
- Patients and Caregivers
- Pharmaceutical and Biotechnology Professionals
- Nurses and Nurse Practitioners
- Rehabilitation Engineers
- Radiologists and Imaging Technologists
- Genetic Counselors
- Industry Representatives
- Neuromuscular specialists
- Rehabilitation specialists
- Radiologists and imaging specialists
- Neuroscientists
- Neurology-related allied health professionals
- Neurologists
- Neurosurgeons
- Neuropsychologists
- Neurophysiologists
- Physiatrists
- Physical therapists and Occupational therapists
- Speech-language pathologists
Neurology Conference Market Overview 2025
- The global neurology market size was approximately $67.3 billion in 2024, projected to grow to $94.8 billion by 2029, with a robust CAGR of 7.1% from 2024 to
- The neuroscience market reached about $35.9 billion in 2024, expected to expand to $48 billion by 2033 at a CAGR of 3.1% during 2025-2033.
- The neurology clinical trials market is valued at $6.22 billion in 2025, forecasted to reach $10.14 billion by 2034, growing at a CAGR of 58%.
- The U.S. neurosurgical devices market was valued over $7.6 billion in 2024, expected to grow at 3.8% CAGR to nearly $10 billion by
Key Growth Drivers
- Rising prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy, and multiple sclerosis due to aging populations and lifestyle factors.
- Advances in neurotherapeutics, neuroimaging, neuroinformatics, and neuroprosthetics are driving demand for innovative treatments and diagnostics..
- Increased R&D investments, government support, and expanding healthcare infrastructure globally, especially in emerging markets like Asia-Pacific.
- Growing focus on neuropsychiatric disorder treatments and clinical trials is accelerating market expansion.
Market Challenges
- Regulatory complexities, high costs, and recruitment challenges in neurology clinical trials..
- Patent expiries of blockbuster drugs and competitive pressures influencing pharmaceutical strategies.
- Need for advanced, targeted drug delivery systems and personalized medicine approaches.
Regional Insights
- North America remains the largest market segment, with significant clinical trial activity and device adoption.
- Emerging economies in Asia-Pacific show rapid growth potential due to increasing healthcare investments and disease burden.
| Global Neurology Market | 67.3 | 94.8 (2029) | Global Neurology Market 67.3 94.8 (2029) 7.1 (2024-2029) |
| Neuroscience Market | 35.9 | 48.0 (2033) | Neuroscience Market 35.9 48.0 (2033) 3.1 (2025-2033) |
| Neurology Clinical Trials | 6.22 | 10.14 (2034) | 5.58 (2025-2034) |
| U.S. Neurosurgical Devices | 7.6 | ~10 (2031) | U.S. Neurosurgical Devices 7.6 ~10 (2031) 3.8 (2024-2031) |
This market outlook underscores the expanding opportunities and innovation in neurology, making the 2025 Neurology Conference a pivotal platform for stakeholders to explore emerging trends, technologies, and collaborations.
Note: For detailed charts, graphs, and images, refer to official market research reports from IMARC Group, BCC Research, and Precedence Research.
1.Board of Directors, Chairman, Trustee, Doctor, Surgeons, Surgical tool technicians, Patients, Primary care, clinical assistants
2.Head of the departments, professors, Lecturers, Technicians, Students
3.Board & Advisors, Chief Executive Officer, Chief Operating Officer, Head of the departments
4.Directors, Head of the departments, Researchers
5.Collaborators, Sponsors, Directors, Researchers
6.Students, PhD scholars, Policy makers, Science Journalists, Writers
7. Social Workers, Mental Health Experts, Students and Residents of Mental Health
Why Register for the International Neurology Conference:
1.Foster connection with attendees from 10+ countries.
2. Learn basics and complex research in brain science and mind science.
3. Explore existing treatment plans – precision psychiatry and neuroplasticity.
4. Interactive sessions with multidisciplinary keynote speakers.
5. Hands-on workshops with VR and neurofeedback devices.
6. Get personalized treatment or therapy plans from renowned healthcare providers.
7. Indulge in demos of the latest neurotech and diagnostic methods.
8. Pitch your research to industry leaders and pave your career path.
9. Solve real-world cases and exchange ideas with fellow researchers.
10. Gain insights on psychedelics and neuroimaging in roundtable discussions.
Whether you’re a returning attendee or a first-time participant the International Neurology and Mental Health Conference 2025 has a lot to offer, Register now and embark on your journey of true excellence!
1. What are the main themes or topics covered at the conference?
The conference will explore cutting-edge topics including neuroplasticity, cognitive neuroscience, neurosurgery advancements, brain trauma, neurodegenerative disorders, neuroimaging, mental health, and the mind-brain connection.
2. Will the conference provide access to the latest research and case studies?
Yes, the event features oral and poster presentations, symposiums, and plenary sessions that highlight the most recent discoveries, innovative treatments, and impactful clinical case studies in neurology.
3. Can I earn CME/CPD credits or certifications from this event?
Yes, the conference is CPD-accredited. Participants will receive a certificate of participation that is valid for continuing professional development purposes. CPD credits are awarded based on the duration of your presentation—typically, 1 credit per minute of active presentation. For example, if your session lasts 25–30 minutes, you will be eligible to receive 25–30 CPD credits.
4. Will there be workshops or hands-on sessions included?
Yes, we are offering interactive workshops and practical sessions led by field experts, providing participants with valuable hands-on learning experiences.
5. Will the organizers provide an invitation letter for visa purposes?
Yes, upon successful registration, we will provide an official invitation letter to assist with your visa application process. Please ensure you apply early, as visa processing times may vary.
6. Are there recommended hotels or travel assistance available?
Yes, we have partnered with several nearby hotels offering special rates for conference attendees. Travel assistance, including accommodation recommendations, will be shared upon registration.
7. Is there airport pick-up or local transport support?
Yes, we offer assistance with local transportation by providing detailed guidance on shuttle services, taxi options, and reliable local transit partners to ensure a smooth arrival and departure. If you have booked accommodations through our recommended hotel partners, we will coordinate with the hotel to arrange airport pick-up and drop-off services accordingly.
8. Will I get a certificate of participation or presentation?
Yes, all registered attendees will receive a Certificate of Participation. Additionally, individuals who present at the conference—whether through oral or poster presentations—will be awarded a Certificate of Presentation recognizing their contribution to the event.
Neurology Conferences 2025 USA
PubScholars Group is delighted to welcome you to the 3rd Edition of the International Neurology Conference 2025, a prestigious gathering that delves into the complexities of the brain and its profound connection to mental health. This year’s theme, “Mind-Brain Connection: Understanding Neuroscience through Mental Health,” highlights the intersection of neurological science and psychological well-being, aiming to bridge cognitive and emotional domains.
The conference will explore key topics such as neuroplasticity, the impact of trauma on brain function, depression, anxiety, and emerging insights into the mind-brain axis. Building on the legacy of our past globally acclaimed Neuroscience Conferences, this edition promises an engaging, interdisciplinary platform for knowledge sharing and collaborative advancement.
We extend our warm invitation to neurologists, psychologists, clinical therapists, neurosurgeons, researchers, and mental health professionals to join us in shaping the future of patient care and neuroscience innovation. Don’t miss this opportunity to contribute to meaningful dialogue, present your research, and expand your professional network.
- Dates: November 15-16, 2025
- Location: Florida, USA
Neurology Conference 2025 - Conference Sessions
Nanhai Maternity and Children Hospital Affiliated to Guangzhou, University of Chinese Medicine CHINA
Presentation Title :- Neuroimaging by Evaluation Nerverenovate and Neuroplasticity of Acupuncture in Children with Cerebral Palsy
MD, Pain Management Center, St. Lukes’s Medical Center – Global City, Taguig City, Metro Manila, Philippines
Presentation Title:- Lumbar sympathetic block as adjunct to management of phantom limb pain in a patient with recurrent squamous cell carcinoma post hemipelvectomy: a case report
Department of Neurology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Keynote Presentation: The Immunochemical pathology of encephalomyeloradi culoneuropathy: A new autoneuroimmune disorder
Ankara University, Department of Biology, Ankara, Türkiye
Presentation Title :- Organic MyExosome®: A triple holistic blend of coffee, ginseng, and ginkgo epden’s as a functional food supplement for the prevention of Alzheimer’s and dementia
Sessions
Post-infectious neurological syndromes involve immune-mediated inflammation triggered by infections, causing conditions like encephalitis, neuropathies, cognitive impairments, and movement disorders. Persistent immune activation or viral remnants may sustain symptoms. SARS-CoV-2 notably increases long-term neurological risks, including cognitive decline and neuroinflammation, impacting quality of life and healthcare systems.
Virtual reality in neurological rehabilitation enhances motor and cognitive recovery by providing immersive, interactive exercises that boost engagement, motivation, and neuroplasticity. It offers real-time feedback, personalized therapy, and safe environments for practicing daily tasks, improving outcomes in stroke, TBI, Parkinson’s, and cognitive impairments with evidence-based effectiveness.
Cross-cultural perspectives reveal that mental health is shaped by cultural beliefs, stigma, and explanatory models, varying from medical to spiritual interpretations. Effective care requires cultural competence, addressing language barriers, diagnostic challenges, and tailoring treatments to respect diverse values, improving engagement, reducing disparities, and enhancing mental health outcomes globally.
Psychedelics enhance neuroplasticity by stimulating 5-HT2A receptors, promoting dendritic growth, synaptogenesis, and plasticity-related gene expression, especially in the prefrontal cortex and hippocampus. These changes facilitate lasting neural circuit remodeling, potentially underpinning therapeutic effects on mood, cognition, and behavior in disorders like depression.
Neuroeconomics integrates neuroscience, psychology, and economics to study how the brain makes value-based decisions. It reveals that decision-making involves multiple interacting brain systems influenced by emotions, biases, and computations, challenging traditional rational choice models. Techniques like fMRI uncover neural activity underlying economic behaviors, improving prediction and understanding of choices.
Integrative neuroscience unifies data across scales—from molecular to behavioral—linking brain structure and function through hierarchical and functional integration. It combines diverse methods to understand complex neural systems, enabling insights into cognition, behavior, and pathology. This approach fosters interdisciplinary research, modeling, and data sharing for a comprehensive brain understanding.
Ethics in neuroscience research addresses informed consent, privacy, data security, and risk-benefit balance, especially for vulnerable populations. Neuroethics guides responsible innovation, ensuring respect for autonomy, beneficence, justice, and transparency. It also tackles dual-use risks and societal impacts, fostering ethical governance and trust in advancing brain science
Adolescence features dynamic brain remodeling, especially in the prefrontal cortex and limbic system, influencing risk-taking and emotional regulation. Stress and adversity can alter neural development, increasing vulnerability to mental health disorders. However, resilience emerges through supportive environments, social buffering, and neuroplasticity, highlighting intervention opportunities to promote adaptive outcomes.
Brain-immune system interactions critically influence mental health by modulating neuroinflammation, synaptic plasticity, and neural signaling. Stress-induced immune activation triggers cytokine release and blood-brain barrier changes, affecting neuronal function and behavior. Dysregulated immune responses contribute to psychiatric disorders, offering novel targets for diagnosis and treatment through psychoneuroimmunology insights.
Emerging brain imaging technologies include high-resolution 7T MRI, AI-driven dynamic imaging, and functional conductivity imaging, enhancing spatial and temporal resolution and enabling direct detection of neural activity. Advances integrate multimodal approaches (fMRI, EEG, ultrasound) and novel algorithms like DeepSTI, improving disease diagnosis, personalized treatment, and understanding brain function across scales.
Aging leads to brain shrinkage, especially in the frontal cortex and hippocampus, reducing neuroplasticity, synaptic function, and white matter integrity. These changes impair memory, attention, and cognitive flexibility. Compensatory mechanisms in the prefrontal cortex may mitigate decline, but variability exists among individuals in aging effects.
Metabolic syndrome impairs cognition via vascular dysfunction, neuroinflammation, oxidative stress, and altered brain lipid metabolism. It reduces cerebrovascular reactivity, leading to white matter damage and brain atrophy, especially in hippocampus and frontal lobes, affecting executive function and increasing risk for cognitive decline.
Gene therapy offers targeted treatment for neurological disorders by delivering corrective genes to affected neurons, potentially reversing genetic defects. It holds promise for inherited diseases like spinal muscular atrophy and Parkinson’s, enabling long-term symptom relief and neural repair through precise molecular interventions.
Emotion processing involves overlapping brain regions including amygdala, hypothalamus, insular cortex, and prefrontal cortex. These circuits operate via hierarchical, parallel processing and feedback loops, integrating subcortical and cortical areas to regulate diverse emotional states and behaviors adaptively
Sleep, especially REM, supports emotional memory processing by modulating hippocampus and amygdala activity. Poor sleep impairs brain regions controlling memory suppression, exacerbating mental health issues like anxiety and depression. Sleep quality is crucial for cognitive and emotional balance.
Emerging biomarkers include neuroimaging markers of brain volume and connectivity, molecular indicators of neuroinflammation, and electrophysiological signatures. These biomarkers improve early diagnosis, track disease progression, and guide personalized treatment in neurodegenerative and psychiatric disorders.
Recognizing neurodiversity promotes acceptance of cognitive and behavioral differences as natural variations. Inclusive care tailors interventions respecting diverse needs, reduces stigma, and enhances engagement, improving mental health outcomes across autism, ADHD, and other neurodevelopmental conditions
Innovations in spinal cord injury focus on neuroregeneration, stem cell therapy, and neuroprosthetics to restore function. Rehabilitation integrates physical therapy with technology-assisted training to enhance plasticity, motor recovery, and quality of life in patients with varying injury severities.
Dysfunction in autonomic regulation causes disorders like dysautonomia, affecting cardiovascular, gastrointestinal, and thermoregulatory systems. These conditions result from neural injury, autoimmune processes, or genetic factors, requiring multidisciplinary management to stabilize autonomic balance and improve symptoms.
Neuroinformatics integrates big data, AI, and computational models to decode brain complexity. Advances enable multi-scale brain mapping, simulation of neural circuits, and personalized medicine approaches, accelerating discovery and translation in neuroscience research and clinical applications.
Innovations in neurotherapeutics focus on targeted drug delivery across the blood-brain barrier using nanocarriers, viral vectors, and implantable devices. These systems improve efficacy and reduce side effects by enabling precise, controlled release of therapeutics for neurological disorders like Parkinson’s, Alzheimer’s, and brain tumors.
Digital health integrates AI, telemedicine, and wearable neurodevices to monitor brain function and deliver personalized neurological care. AI algorithms analyze brain signals to optimize treatments such as neurostimulation and rehabilitation, enhancing patient outcomes and enabling adaptive, real-time interventions.
Neurovascular coupling ensures cerebral blood flow matches neuronal activity, vital for brain function. Disruptions occur in hypertension, Alzheimer’s, and stroke, impairing blood flow regulation and contributing to cognitive decline. Targeting oxidative stress and vascular dysfunction offers therapeutic potential to restore neurovascular health.
Behavioral genetics uses genomic sequencing and transcriptomics to identify gene variants influencing neurological and psychiatric disorders. This approach reveals molecular pathways underlying cognition, mood, and behavior, advancing understanding of disease mechanisms and enabling development of targeted interventions.
Emerging neurodegenerative therapies include stem cell transplantation, gene editing, immunotherapy, and neurotrophic factors. These aim to replace lost neurons, modulate immune responses, and promote neural repair, showing promise in preclinical and clinical trials for diseases like Alzheimer’s and Parkinson’s.
AI enhances neurology by integrating genetic, imaging, and clinical data to predict disease progression and tailor treatments. It supports early diagnosis, optimizes therapy plans, and enables precision medicine, improving outcomes and reducing trial-and-error in managing complex neurological disorders.
Pain perception involves complex neural circuits integrating sensory, emotional, and cognitive components. Advances in neuroimaging and molecular biology reveal mechanisms of chronic pain and central sensitization, guiding development of novel analgesics and neuromodulation therapies to improve pain management.
Brain-computer interfaces (BCIs) decode neural signals to control external devices, restoring motor and communication functions in neurological impairments. Advances in signal processing and AI enhance BCI accuracy and usability, enabling neuroprosthetics that improve independence for patients with paralysis or sensory loss.
Environmental factors like toxins, nutrition, and stress influence brain development, affecting neural connectivity and cognitive outcomes. Early-life exposures can increase risks of neurodevelopmental disorders. Understanding these impacts informs prevention strategies and interventions promoting healthy brain maturation.
Psychosocial stress activates neuroendocrine and immune pathways, altering neurotransmission and neural plasticity. Chronic stress induces neuroinflammation and structural brain changes, contributing to mental health disorders. Research on these mechanisms supports development of stress resilience and therapeutic approaches.
Important Dates
- Abstract Submission are Open..!!! - April 30, 2025
- Early Bird Registration Deadline..!! - May-15, 2025
- Final Call Registration Deadline..!! - August, 31st, 2025
Neurology Conferences 2025 USA
In 2025, join us in unfolding the brain’s mysteries and connecting them to the mind, bridging the gap between cognitive and emotional well-being as experts discuss how neuroscience revolutionizes our mental health. Our vision, “Mind-Brain Connection: Understanding Neuroscience through Mental Health,” will pave the way for various sub-themes, including neuroplasticity, the impact of trauma on the brain, depression, and anxiety, and key topics that connect our mind-brain axis. Carrying forward the Legacy of past successful World Neuroscience Conferences, we invite neurologists, psychologists, clinical therapists, neurosurgeons, researchers, and all enthusiasts to this global platform where we can understand and improve mental health patient care through neurological techniques.
- Dates: November 15-16, 2025
- Location: Florida, USA
Neurology Conference 2025 Indexed In
Why Register for the Neurology Conference 2025 USA?
- Panel Discussion : Widen your knowledge in the arena of brain injury and how it causes various mental distress.
- Interactive Workshops : Explore the latest Neoroimagining tools and understand the brain activity of people with PTSD.
- Support Interest Groups (SIGS) : Connect and collaborate with attendees researching neuropsychiatry and neurobehavioral therapy.
- Attend Neurology Conference 2025 & Earn CPD credits : Listen to patients undergoing neurological therapies for depression, anxiety, and mental health issues.
- Networking opportunities: Connect with Industry leaders, researchers, and incubators to facilitate partnerships in mind-brain studies.
- Futuristic Treatment plans : Learn AI’s role in neurosurgery, VR-based therapies, and the latest technological advancements in the field.
Speakers
CPD Accredited
Past Edition Highlights
Early Bird Registration Closes on May 15, 2025..!!
Media Partners/Collaboration
Past Conference Gallery
Testimonials
Upcoming Conferences 2025-2026
